TNDM
Income statement / Annual
Last year (2024), Tandem Diabetes Care, Inc.'s total revenue was $940.20 M,
an increase of 25.74% from the previous year.
In 2024, Tandem Diabetes Care, Inc.'s net income was -$96.03 M.
See Tandem Diabetes Care, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$940.20 M |
$747.72 M |
$801.22 M |
$702.80 M |
$498.83 M |
$362.31 M |
$183.87 M |
$107.60 M |
$84.25 M |
$72.85 M |
| Cost of Revenue |
$450.63 M
|
$380.03 M
|
$388.23 M
|
$326.58 M
|
$238.31 M
|
$168.09 M
|
$94.04 M
|
$63.51 M
|
$60.66 M
|
$46.27 M
|
| Gross Profit |
$489.57 M
|
$367.69 M
|
$412.99 M
|
$376.22 M
|
$260.52 M
|
$194.21 M
|
$89.82 M
|
$44.09 M
|
$23.59 M
|
$26.58 M
|
| Gross Profit Ratio |
0.52
|
0.49
|
0.52
|
0.54
|
0.52
|
0.54
|
0.49
|
0.41
|
0.28
|
0.36
|
| Research and Development Expenses |
$198.88 M
|
$169.67 M
|
$139.11 M
|
$92.05 M
|
$63.57 M
|
$45.20 M
|
$29.23 M
|
$20.66 M
|
$18.81 M
|
$16.96 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$86.38 M
|
$82.83 M
|
$78.62 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.00 M
|
| Selling, General & Administrative Expenses |
$389.82 M
|
$352.50 M
|
$335.68 M
|
$261.51 M
|
$204.90 M
|
$165.74 M
|
$105.23 M
|
$86.38 M
|
$82.83 M
|
$78.62 M
|
| Other Expenses |
$0.00
|
$78.75 M
|
-$4,000.00
|
$0.00
|
$0.00
|
-$7.88 M
|
-$77.93 M
|
-$10.08 M
|
-$5.41 M
|
-$3.40 M
|
| Operating Expenses |
$588.70 M
|
$600.92 M
|
$474.80 M
|
$353.56 M
|
$268.48 M
|
$210.93 M
|
$134.45 M
|
$107.04 M
|
$101.64 M
|
$95.58 M
|
| Cost And Expenses |
$1.04 B
|
$980.95 M
|
$863.03 M
|
$680.15 M
|
$506.79 M
|
$379.03 M
|
$228.50 M
|
$170.55 M
|
$162.30 M
|
$141.85 M
|
| Interest Income |
$17.99 M
|
$22.86 M
|
$6.06 M
|
$674,000.00
|
$1.57 M
|
$3.27 M
|
$1.46 M
|
$239,000.00
|
$296,000.00
|
$337,000.00
|
| Interest Expense |
$5.51 M
|
$9.88 M
|
$4.31 M
|
$4.31 M
|
$12.15 M
|
$78,000.00
|
$7.58 M
|
$11.34 M
|
$5.71 M
|
$3.74 M
|
| Depreciation & Amortization |
$0.00
|
$15.72 M
|
$14.33 M
|
$13.85 M
|
$10.45 M
|
$6.07 M
|
$5.82 M
|
$6.87 M
|
$5.49 M
|
$4.83 M
|
| EBITDA |
-$99.13 M |
-$194.66 M |
-$72.31 M |
$36.50 M |
-$13.03 M |
-$18.45 M |
-$109.16 M |
-$54.82 M |
-$72.27 M |
-$63.84 M |
| EBITDA Ratio |
-0.11
|
-0.26
|
-0.04
|
0.03
|
-0.02
|
-0.05
|
-0.24
|
-0.58
|
-0.93
|
-0.95
|
| Operating Income Ratio |
-0.11
|
-0.31
|
-0.08
|
0.01
|
-0.02
|
-0.05
|
-0.24
|
-0.58
|
-0.93
|
-0.95
|
| Total Other Income/Expenses Net |
$7.26 M
|
$12.98 M
|
-$4,000.00
|
-$6.75 M
|
-$28.33 M
|
-$7.88 M
|
-$77.93 M
|
-$10.08 M
|
-$5.41 M
|
-$3.40 M
|
| Income Before Tax |
-$91.87 M
|
-$220.25 M
|
-$92.85 M
|
$15.90 M
|
-$36.28 M
|
-$24.60 M
|
-$122.56 M
|
-$73.03 M
|
-$83.46 M
|
-$72.41 M
|
| Income Before Tax Ratio |
-0.1
|
-0.29
|
-0.12
|
0.02
|
-0.07
|
-0.07
|
-0.67
|
-0.68
|
-0.99
|
-0.99
|
| Income Tax Expense |
$4.16 M
|
$2.36 M
|
$1.74 M
|
$335,000.00
|
-$1.90 M
|
$149,000.00
|
$51,000.00
|
$8,000.00
|
-$15,000.00
|
$10,000.00
|
| Net Income |
-$96.03 M
|
-$222.61 M
|
-$94.59 M
|
$15.57 M
|
-$34.38 M
|
-$24.75 M
|
-$122.61 M
|
-$73.03 M
|
-$83.45 M
|
-$72.42 M
|
| Net Income Ratio |
-0.1
|
-0.3
|
-0.12
|
0.02
|
-0.07
|
-0.07
|
-0.67
|
-0.68
|
-0.99
|
-0.99
|
| EPS |
-1.47 |
-3.43 |
-1.47 |
0.25 |
-0.56 |
-0.42 |
-2.55 |
-12.86 |
-27.3 |
-25.04 |
| EPS Diluted |
-1.47 |
-3.43 |
-1.47 |
0.24 |
-0.56 |
-0.42 |
-2.55 |
-12.86 |
-27.3 |
-25.04 |
| Weighted Average Shares Out |
$65.45 M
|
$64.90 M
|
$64.15 M
|
$63.00 M
|
$60.99 M
|
$58.51 M
|
$48.13 M
|
$5.68 M
|
$3.06 M
|
$2.89 M
|
| Weighted Average Shares Out Diluted |
$65.45 M
|
$64.97 M
|
$64.15 M
|
$64.35 M
|
$60.99 M
|
$58.51 M
|
$48.13 M
|
$5.68 M
|
$3.06 M
|
$2.89 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
